Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide products. - Mattei AE; Roberts BJ; Lelias S; Miah S; Howard KE; Weaver JL; Verthelyi D; Pang ES; Edwards K; De Groot AS (Frontiers in immunology, 2025)